Given that it has important roles in regulation of motile phenotype of pancreatic cancer cells, DPYSL3 may be an excellent candidate for anti-metastasis therapeutic strategies, which may ultimately lead to a reduction in the large number of deaths caused by this devastating disease. This evidence concerns the gene DPYSL3 and familial pancreatic carcinoma.